Showing 6,006 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Changing treatment

African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir

News
9 March 2021
Bone & joint problems

Alendronate can prevent bone loss in people starting HIV treatment

News
9 March 2021
Injectable & long-acting PrEP

Reformulated islatravir implant should provide PrEP for over a year

News
9 March 2021
PrEP

Sex, PrEP and HIV in trans and non-binary people A research briefing

About HIV
March 2021
Health monitoring in resource-limited settings

Near point-of-care viral load tests slash waiting times in seven African countries

News
4 March 2021
Vaccinations & immunisations

US: Interim Guidance for COVID-19 and Persons with HIV

Editor's pick
HIV.gov
1 March 2021
Injectable & long-acting HIV treatment

ViiV Seeks FDA Approval for Cabenuva Dosed Every 2 Months for HIV

Editor's pick
Monthly Prescribing Reference
26 February 2021
HIV treatment

Stribild Detailed information

About HIV
February 2021
HIV treatment

Stribild Factsheet

About HIV
February 2021
HIV treatment

Modern ART paints Soweto bright pink to advertise the latest HIV drug

Editor's pick
Daily Maverick
19 February 2021
Treatment simplification strategies

Similar rate of severe clinical outcomes with two drug vs three drug HIV treatment combinations

News
17 February 2021
Sexually transmitted infections prevention

Antibiotics to prevent STIs – for or against?

News
10 February 2021
New & experimental HIV treatments

ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-resistant HIV

Editor's pick
ViiV Healthcare press release
8 February 2021
Antibody-based prevention

Why broadly neutralising antibodies might be the next big thing in HIV

Editor's pick
Spotlight
8 February 2021
HIV treatment

Where to get HIV treatment

About HIV
February 2021
Low CD4 count

Diagnosed with HIV at a low CD4 count

About HIV
January 2021
Injectable & long-acting HIV treatment

Cabenuva, the First Long-Acting Injectable HIV Regimen, Is Here; Now, Who Will Take It?

Editor's pick
TheBody
29 January 2021
HIV treatment

Raltegravir (Isentress) Detailed information

About HIV
January 2021
HIV treatment

Raltegravir Factsheet

About HIV
January 2021
HIV treatment

Elvitegravir Detailed information

About HIV
January 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
Antibody-based prevention

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

News
27 January 2021
PrEP policies & guidelines

European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do

News
27 January 2021
Injectable & long-acting HIV treatment

Previous Intravenous Drug Use May Impact Women's Comfort With Injectable HIV Medications

Editor's pick
American Journal of Managed Care
25 January 2021